Real-world data analysis of adjuvant capecitabine for triple-negative breast cancer after neoadjuvant chemotherapy
{{output}}
Purpose: Evaluate real-world outcomes in three cohorts of patients with early-stage triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NAC): (1) patients who achieved pathological complete response (pCR);... ...
